Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma.
Parakh, Sagun
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. [electronic resource] - Asia-Pacific journal of clinical oncology Feb 2019 - 26-30 p. digital
Publication Type: Journal Article
1743-7563
10.1111/ajco.13100 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Brain Neoplasms--drug therapy
Female
Humans
Ipilimumab--administration & dosage
Male
Melanoma--drug therapy
Middle Aged
Nivolumab--administration & dosage
Prognosis
Retrospective Studies
Survival Rate
Young Adult
Real-world efficacy and toxicity of combined nivolumab and ipilimumab in patients with metastatic melanoma. [electronic resource] - Asia-Pacific journal of clinical oncology Feb 2019 - 26-30 p. digital
Publication Type: Journal Article
1743-7563
10.1111/ajco.13100 doi
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Brain Neoplasms--drug therapy
Female
Humans
Ipilimumab--administration & dosage
Male
Melanoma--drug therapy
Middle Aged
Nivolumab--administration & dosage
Prognosis
Retrospective Studies
Survival Rate
Young Adult